SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

News > Research

Read more breaking news

 

 
News in brief

Science builds for attention boosting potential of Cognizin Citicoline

18-May-2011
Last updated on 18-May-2011 at 18:28 GMT2011-05-18T18:28:23Z

Science builds for attention boosting potential of Cognizin Citicoline

A daily 250 milligram dose of Kyowa Hakko’s Cognizin Citicoline ingredient may be effective for improving attention, suggest new findings from the University of Utah Brain Institute.

According to findings presented at the 66th Annual Meeting of the Society of Biological Psychiatry in San Francisco, a dose of 250 milligrams of the ingredient was just as effective as 500 milligrams for boosting the attentional function of health middle-aged women.

"Citicoline has been shown to have a variety of cognitive-enhancing and neuroregenerative properties in pre-clinical and clinical studies," said Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah.

"Our findings suggest that citicoline may mitigate the cognitive decline associated with normal aging and may ameliorate attentional deficits associated with psychiatric disorders," she add.

Sixty healthy women were randomized to one of three groups: The first group received a placebo, while the second and third groups received a daily dose of Cognizin Citicoline of 250 or 500 milligrams, respectively, for 28 days.

Using the Continuous Performance Test II (CPT-II), the researchers found that both supplement groups committed fewer errors, particularly those associated with non-target stimuli, said the researchers, thereby indicating an improvement in attention.

Related products